InvestorsHub Logo
Followers 160
Posts 21505
Boards Moderated 1
Alias Born 07/17/2006

Re: saxonia40271 post# 132

Friday, 06/24/2022 11:15:35 AM

Friday, June 24, 2022 11:15:35 AM

Post# of 156
Sure looks to me like AGE is owned by and will become Juvenescence … your thoughts??

Per last filing and many more , 13 Million dollar credit line, already used 10 million or 11 ?

Item 3.02 Unregistered Sales of Equity Securities.

In connection with AgeX’s June 6, 2022 draw of loan funds under the Secured Note (as defined in Item 2.03 of this Report), AgeX will issue to Juvenescence upon approval for listing by the NYSE American warrants to purchase 703,234 shares of AgeX common stock (“Warrants”) at an exercise price of $0.711 per share.

Item 9.01 - Financial Statements and Exhibits.

Exhibit Number Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AGEX THERAPEUTICS, INC.

Date: June 10, 2022 By: /s/ Andrea E. Park
Chief Financial Officer


___________________________________________________________________
*** Yes, its time to make money ***

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AGE News